Fenwick & West represented Royalty Pharma, and Orrick Herrington & Sutcliffe represented Ferring Pharmaceuticals in the deal. Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals announced...
Royalty Pharma $500 Million Royalty Agreement with Ferring Pharmaceuticals
Ferring Pharmaceuticals’ Collaboration with Hybio Pharmaceutical Co.
Sidley Austin advised Ferring Pharmaceuticals on the deal. Ferring Pharmaceuticals (China) Co., Ltd. announced its strategic collaboration with Hybio Pharmaceutical Co., Ltd. where the Marketing Authorization of Cetrotide...